Lifecore Biomedical, Inc. (LFCR) stock
LFCRNasdaqPharmaceutical PreparationsFiscal year ends May 25
$6.40+0.00 (0.00%)
Close on Nov 12, 2026Market cap $242.26MP/E –Yield –
Lifecore Biomedical operating margin
Operating margin is operating income as a percentage of revenue.
Lifecore Biomedical's operating margin for the twelve months ending May 25, 2025 was -13.4%. For fiscal 2025 it was -13.4%, against -6.9% the year before. The highest annual figure on record is 5.6% in fiscal 2013.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | May 25, 2025 | -13.4% | −6.5 |
| FY2024 | May 26, 2024 | -6.9% | +14.2 |
| FY2023 | May 28, 2023 | -21.1% | −10.5 |
| FY2022 | May 29, 2022 | -10.6% | −1.9 |
| FY2021 | May 30, 2021 | -8.7% | +7.4 |
| FY2020 | May 31, 2020 | -16.2% | −17.1 |
| FY2019 | May 26, 2019 | 1.0% | −1.6 |
| FY2018 | May 27, 2018 | 2.6% | −0.5 |
| FY2017 | May 28, 2017 | 3.1% | +7.4 |
| FY2016 | May 29, 2016 | -4.3% | −7.7 |
| FY2015 | May 31, 2015 | 3.4% | −0.8 |
| FY2014 | May 25, 2014 | 4.2% | −1.4 |
| FY2013 | May 26, 2013 | 5.6% | +1.0 |
| FY2012 | May 27, 2012 | 4.6% | +1.7 |
| FY2011 | May 29, 2011 | 2.9% | −0.4 |
| FY2010 | May 30, 2010 | 3.4% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2027CQ1 2026 | Sep 30, 2026 | -3.5% | +43.4 |
| Q4 FY2025CQ2 2025 | May 25, 2025 | 14.6% | +8.9 |
| Q3 FY2025CQ1 2025 | Feb 23, 2025 | -25.7% | −23.2 |
| Q2 FY2025CQ4 2024 | Nov 24, 2024 | -6.0% | −1.1 |
| Q1 FY2025CQ3 2024 | Aug 25, 2024 | -46.9% | −11.8 |
| Q4 FY2024CQ2 2024 | May 26, 2024 | 5.7% | +27.0 |
| Q3 FY2024CQ1 2024 | Feb 25, 2024 | -2.5% | +22.1 |
| Q2 FY2024CQ4 2023 | Nov 26, 2023 | -4.9% | +19.6 |
| Q1 FY2024CQ3 2023 | Aug 27, 2023 | -35.1% | −21.3 |
| Q4 FY2023CQ2 2023 | May 28, 2023 | -21.3% | −12.4 |
| Q3 FY2023CQ1 2023 | Feb 26, 2023 | -24.6% | +2.7 |
| Q2 FY2023CQ4 2022 | Nov 27, 2022 | -24.5% | −38.9 |
| Q1 FY2023CQ3 2022 | Aug 28, 2022 | -13.8% | +5.1 |
| Q4 FY2022CQ2 2022 | May 29, 2022 | -8.9% | +5.8 |
| Q3 FY2022CQ1 2022 | Feb 27, 2022 | -27.4% | −27.6 |
| Q2 FY2022CQ4 2021 | Nov 28, 2021 | 14.4% | +8.6 |
| Q1 FY2022CQ3 2021 | Aug 29, 2021 | -18.9% | +27.8 |
| Q4 FY2021CQ2 2021 | May 30, 2021 | -14.8% | −14.5 |
| Q3 FY2021CQ1 2021 | Feb 28, 2021 | 0.3% | +10.1 |
| Q2 FY2021CQ4 2020 | Nov 29, 2020 | 5.8% | +10.0 |
| Q1 FY2021CQ3 2020 | Aug 30, 2020 | -46.8% | −43.6 |
| Q4 FY2020CQ2 2020 | May 31, 2020 | -0.3% | −1.9 |
| Q3 FY2020CQ1 2020 | Feb 23, 2020 | -9.8% | −11.9 |
| Q2 FY2020CQ4 2019 | Nov 24, 2019 | -4.2% | −4.2 |
| Q1 FY2020CQ3 2019 | Aug 25, 2019 | -3.2% | −3.0 |
| Q4 FY2019CQ2 2019 | May 26, 2019 | 1.6% | −4.1 |
| Q3 FY2019CQ1 2019 | Feb 24, 2019 | 2.1% | −0.3 |
| Q2 FY2019CQ4 2018 | Nov 25, 2018 | 0.0% | +0.6 |
| Q1 FY2019CQ3 2018 | Aug 26, 2018 | -0.2% | −2.6 |
| Q4 FY2018CQ2 2018 | May 27, 2018 | 5.7% | +4.4 |
| Q3 FY2018CQ1 2018 | Feb 25, 2018 | 2.4% | −0.9 |
| Q2 FY2018CQ4 2017 | Nov 26, 2017 | -0.6% | −3.5 |
| Q1 FY2018CQ3 2017 | Aug 27, 2017 | 2.4% | −2.7 |
| Q4 FY2017CQ2 2017 | May 28, 2017 | 1.3% | −3.3 |
| Q3 FY2017CQ1 2017 | Feb 26, 2017 | 3.3% | – |
| Q2 FY2017CQ4 2016 | Nov 27, 2016 | 3.0% | – |
| Q1 FY2017CQ3 2016 | Aug 28, 2016 | 5.0% | – |
| Q4 FY2016CQ2 2016 | May 29, 2016 | 4.6% | – |
See a number that looks wrong?